Search

for
Search:

Did you mean Cardiovascular Risk Marker?

Glossary Cardiovascular Risk Marker

measurable biological characteristic indicating likelihood of cardiovascular diseases

A Cardiovascular Risk Marker, also known as a Cardiovascular Risk Factor, is a measurable biological characteristic that indicates an individual's likelihood of developing cardiovascular diseases, such as heart attacks or strokes. Common examples include high blood pressure, high cholesterol levels, and elevated blood sugar. These markers help healthcare professionals assess and manage a patient's risk for heart-related conditions.

Related Terms

Research

5 / 1000+ results

research Cardiovascular risk markers and thyroid status in young Indian women with polycystic ovarian syndrome: A case-control study

5 citations , April 2014 in “Journal of Obstetrics and Gynaecology Research”

This study found that young women with PCOS had normal thyroid function but showed alterations in lipid metabolism, which may predispose unmarried women in this group to cardiovascular diseases.

research Cardiovascular risk markers in premature canities

2 citations , July 2022 in “Indian Journal of Dermatology Venereology and Leprology”

This study found that patients with premature greying of hair had significant abnormalities in cardiovascular risk markers, including elevated IL-6 levels, compared to healthy controls.

research Inflammatory markers and Lp(a) levels as cardiovascular risk factors in androgenetic alopecia

7 citations , January 2016 in “Clinical Hemorheology and Microcirculation”

In this study, patients with androgenetic alopecia showed no difference in insulin resistance or prevalence of metabolic syndrome but had higher cardiovascular risk due to increased inflammatory markers and lipoprotein(a) levels.

Ultrasonographic and Laboratory Markers of Metabolic and Cardiovascular Disease Risk in Obese Women with Polycystic Ovary Syndrome

research Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome

45 citations , February 2012

Among obese women potentially eligible for combined oral contraceptives, this study observed a higher frequency of non-alcoholic fatty liver disease in those with polycystic ovary syndrome.

The Utilization of Cardiac Risk Ratio and Non-HDL Cholesterol Markers to Assess Cardiovascular Risk in Type 2 Diabetes Males with Lowered Serum DHT

research The utilisation of cardiac risk ratio and non-HDL cholesterol markers to assess cardiovascular risk in type 2 diabetes males with lowered serum DHT

July 2022 in “International Journal of Health Sciences”

This study assessed lipid parameters and serum DHT levels in type 2 diabetes patients, but the abstract does not specify the findings about their association.

View more "cardiovascular risk markers" in research →

Community Join

5 / 193 results

community Pattern hair loss before the age of 35 is associated with higher chances of prostate cancer, cardiovascular diseases, and metabolic syndrome later in life

1075 upvotes 3 months ago

Pattern hair loss before age 35 may be linked to higher risks of prostate cancer, cardiovascular diseases, and metabolic syndrome later in life. Finasteride is discussed as a treatment that may lower PSA levels and potentially prevent prostate issues.

community Being Safe on Oral Minoxidil: tl;dr on the literature.

51 upvotes 1 year ago

Oral minoxidil is effective for hair loss but can cause cardiovascular side effects, such as pericardial effusion, especially in those with genetic predispositions. Starting with low doses and monitoring cardiovascular health are advised to reduce risks.

community Male pattern baldness is not cosmetic.

224 upvotes 9 months ago

Male pattern baldness is linked to health risks and should be treated medically. Finasteride is effective and should be insurance-covered.

community Interesting new publication suggesting that MPB should be assessed as a early warning sign for type-2 diabetes.

15 upvotes 8 years ago

Male pattern baldness (MPB) may be an early warning sign for type 2 diabetes due to its association with insulin resistance. Treatments discussed include testosterone therapy and finasteride, which affects hormone levels related to hair loss and insulin sensitivity.

community Started Finasteride 1mg daily at 20 years and 8 months old. 18 months later (now). Opinions? Dad's side of the family are flaming me day and night to just give up.

in Progress Pictures 14 upvotes 1 month ago

A 22-year-old started taking finasteride at 20 to combat hair loss, experiencing significant shedding initially but no side effects. Despite challenges in obtaining dutasteride and oral minoxidil in Sweden, the user is content with the current hairline and considering additional treatments like microneedling.

View more "cardiovascular risk markers" in community →

Learn

— no results

Try a deeper search in learn →

Experts

— no results

Try a deeper search in experts →

Clinics

— no results

Try a deeper search in clinics →